The Urokinase Receptor (U-Par)-A Link Between Tumor Cell Dormancy and Minimal Residual Disease in Bone Marrow?

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - United Kingdom
doi 10.1111/j.1600-0463.2008.00997.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Urokinase-Receptor (U-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/Dormancy, Clinical Outcome and Minimal Residual Disease

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2006English

Ficolled Bone Marrow Is Superior to Bone Marrow Buffy Coat for Detection of Minimal Residual Disease in Multiple Myeloma

Hematology
Hematology
2019English

The Prognostic Significance of Hematogones and CD34+ Myeloblasts in Bone Marrow for Adult B-Cell Lymphoblastic Leukemia Without Minimal Residual Disease

Scientific Reports
Multidisciplinary
2019English

Minimal Residual Disease

Leukemia Supplements
2012English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Monitoring of Minimal Residual Disease in Adult Acute Myeloid Leukemia Using Peripheral Blood as an Alternative Source to Bone Marrow

Haematologica
Hematology
2007English

Bone Marrow Bi-Hypoplasia in a Dog With a Sertoli Cell Tumor

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia
Veterinary
2017English

Workshop on Minimal Residual Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Escape From Tumor Cell Dormancy

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy